To better understand the role of eEF-2K signalling in PaCa progression, its expression in patients’ tumours samples should be analysed, its association with downstream pathways must be investigated, and its clinical significance in survival and drug resistance should be determined. Here, EEF2K is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.